Arctigenin increases hemeoxygenase-1 gene expression by modulating PI3K/AKT signaling pathway in rat primary astrocytes

Biomolecules and Therapeutics

Volumn 22, Issue 6, 2014, Pages 497-502

  Jeong, Yeon Hui ^a   Park, Jin Sun ^a   Kim, Dong Hyun ^b   Kim, Hee Sun ^a  

^a Ewha Womans University School of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Arctigenin; Astrocyte; Hemeoxygenase 1; Nrf2 ARE axis; PI3K AKT

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARCTIGENIN; HEME OXYGENASE 1; HYDROGEN PEROXIDE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

RATTUS;

EID: 84912531595     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2014.121     Document Type: Article

References (32)

1. Chen, J. H., Huang, S. M., Tan, T. W., Lin, H. Y., Chen, P. Y., Yeh, W. L., Chou, S. C., Tsai, C. F., Wei, I. H. and Lu, D. Y. (2012) Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. Int. Immunopharmacol. 12, 94-100.
2. Cho, M. K., Jang, Y. P., Kim, Y. C. and Kim, S. G. (2004) Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: the role in TNF-alpha inhibition. Int. Immunopharmacol. 4, 1419-1429.
3. Dallerac, G., Chever, O. and Rouach, N. (2013) How do astrocytes shape synaptic transmission? Insights from electrophysiology. Front. Cell. Neurosci. 7, 159.
4. de Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J., Drukarch, B., Hoozemans, J. and van Horssen, J. (2008) Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med. 45, 1375-1383.
5. Fan, T., Jiang, W. L., Zhu, J. and Feng Zhang, Y. (2012) Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation. Biol. Pharm. Bull. 35, 2004-2009.
6. Huang, S. L., Yu, R. T., Gong, J., Feng, Y., Dai, Y. L., Hu, F., Hu, Y. H., Tao, Y. D. and Leng, Y. (2012) Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia 55, 1469-1481.
7. Hyam, S. R., Lee, I. A., Gu, W., Kim, K. A., Jeong, J. J., Jang, S. E., Han, M. J. and Kim, D. H. (2013) Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages. Eur. J. Pharmacol. 708, 21-29.
8. Jang, Y. P., Kim, S. R., Choi, Y. H., Kim, J., Kim, S. G., Markelonis, G. J., Oh, T. H. and Kim, Y. C. (2002) Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J. Neurosci. Res. 68, 233-240.
9. Jung, J. S., Shin, J. A., Park, E. M., Lee, J. E., Kang, Y. S., Min, S. W., Kim, D. H., Hyun, J. W., Shin, C. Y. and Kim, H. S. (2010) Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide- stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J. Neurochem. 115, 1668-1680.
10. Kou, X., Qi, S., Dai, W., Luo, L. and Yin, Z. (2011) Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway. Int. Immunopharmacol. 11, 1095-1102.
11. Lee, E. J. and Kim, H. S. (2011) Inhibitory mechanism of MMP-9 gene expression by ethyl pyruvate in lipopolysaccharide-stimulated BV2 microglial cells. Neurosci. Lett. 493, 38-43.
12. Lee, J. M., Li, J., Johnson, D. A., Stein, T. D., Kraft, A. D., Calkins, M. J., Jakel, R. J. and Johnson, J. A. (2005) Nrf2, a multi-organ protector? FASEB J. 19, 1061-1066.
13. Lee, J. S. and Surh, Y. J. (2005) Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224, 171-184.
14. Li, D., Liu, Q., Jia, D., Dou, D., Wang, X. and Kang, T. (2014) Protective effect of arctigenin against MPP+ and MPTP-induced neurotoxicity. Planta Med. 80, 48-55.
15. Li, M. H., Cha Y. N. and Surh Y. J. (2006) Peroxynitrite induces HO-1 expression via PI3K/Akt-dependent activation of NF-E2-related factor 2 in PC12 cells. Free Radic. Biol. Med. 41, 1079-1091.
16. Lim, J. H., Kim, K. M., Kim, S. W., Hwang, O. and Choi, H. J. (2008) Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacol. Res. 57, 325-331.
17. Martin, D., Rojo, A. I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., De, Galarreta, C.M. and Cuadrado, A. (2004) Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/ Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 279, 8919-8929.
18. Mates, J. M. (2000) Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 153, 83- 104.
19. Otterbein, L. E., Soares, M. P., Yamashita, K. and Bach, F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455.
20. Park, J. H., Hong, Y. J., Moon E., Kim S. A., and Kim, S. Y. (2011a) Forsythiae fructus and its active component, arctigenin, provide neuroprotection by inhibiting neuroinflammation. Biomol. Ther. 19, 425-430.
21. Park, J. S., Jung, J. S., Jeong, Y. H., Hyun, J. W., Le, T. K., Kim, D. H., Choi, E. C. and Kim, H. S. (2011b) Antioxidant mechanism of isoflavone metabolites in hydrogen peroxide-stimulated rat primary astrocytes: critical role of hemeoxygenase-1 and NQO1 expression. J. Neurochem. 119, 909-919.
22. Park, J. S. and Kim, H. S. (2014) Regulation of hemeoxygenase-1 gene expression by Nrf2 and c-Jun in tertiary butylhydroquinonestimulated rat primary astrocytes. Biochem. Biophys. Res. Commun. 447, 672-677.
23. Park, J. S., Woo, M. S., Kim, D. H., Hyun, J. W., Kim, W. K., Lee, J. C. and Kim, H. S. (2007) Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. J. Pharmacol. Exp. Ther. 320, 1237-1245.
24. Ryter, S. W., Alam, J. and Choi, A. M. (2006) Heme oxygenase-1/ carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650.
25. Shi, X., Sun, H., Zhou, D., Xi, H. and Shan, L. (2014) Arctigenin attenuates lipopolysaccharide-induced acute lung injury in rats. Inflammation [Epub ahed of print]
26. Surh Y. J. (2003) Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3, 768-780.
27. Syapin, P. J. (2008) Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br. J. Pharmacol. 155, 623-640.
28. Vargas, M. R. and Johnson, J. A. (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 11, e17.
29. Wang, H. Q., Xu, Y. X. and Zhu, C. Q. (2012) Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity. Neurotox. Res. 21, 368-378.
30. Woo, M. S., Jang, P. G., Park, J. S., Kim, W. K., Joh, T. H. and Kim, H. S. (2003) Selective modulation of lipopolysaccharide-stimulated cytokine expression and mitogen-activated protein kinase pathways by dibutyryl-cAMP in BV2 microglial cells. Brain Res. Mol. Brain Res. 113, 86-96.
31. Wu, R. M., Sun, Y. Y., Zhou, T. T., Zhu, Z. Y., Zhuang, J. J., Tang, X., Chen, J., Hu, L. H. and Shen, X. (2014) Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways. Acta Pharmacol. Sin. 35, 1274-1284.
32. Zhu, Z., Yan, J., Jiang, W., Yao, X. G., Chen, J., Chen, L., Li, C., Hu, L., Jiang, H. and Shen, X. (2013) Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both beta-amyloid production and clearance. J. Neurosci. 33, 13138-13149.